fusidic acid has been researched along with vancomycin in 98 studies
Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (vancomycin) | Trials (vancomycin) | Recent Studies (post-2010) (vancomycin) |
---|---|---|---|---|---|
1,742 | 117 | 344 | 16,808 | 773 | 7,589 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 36 (36.73) | 18.7374 |
1990's | 17 (17.35) | 18.2507 |
2000's | 21 (21.43) | 29.6817 |
2010's | 20 (20.41) | 24.3611 |
2020's | 4 (4.08) | 2.80 |
Authors | Studies |
---|---|
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Badiou, C; Benito, Y; Bes, M; Boisset, S; Dumitrescu, O; Etienne, J; Lina, G; Reverdy, ME; Vandenesch, F | 1 |
Kwon, DH; Lu, CD | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A | 1 |
Hawser, S; Islam, K; Laue, H; Lociuro, S; Seguin, A; Valensise, T | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
Apajalahti, J; Fox, J; Frimodt-Møller, N; He, H; Li, J; Nation, RL; Poudyal, A; Siikanen, O; Vaara, M; Vaara, T | 1 |
Duerink, DO; Fluit, AC; Goessens, WH; Hadi, U; Horst-Kreft, D; Kuntaman, K; Lemmens-den Toom, N; Lestari, ES; Pastink, M; Severin, JA; Snijders, SV; van Belkum, A; van Wamel, W; Verbrugh, HA | 1 |
Athanassopoulos, CM; Dinos, GP; Garnelis, T; Kalpaxis, DL; Kostopoulou, ON; Kournoutou, GG; Leotsinidis, M; Magoulas, GE; Papaioannou, D | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Abouf, M; Abutaleb, NS; Chen, L; Elsebaei, MM; Ghiaty, A; Hegazy, YA; Malwal, SR; Mayhoub, AS; Mohammad, H; Oldfield, E; Seleem, MN; Zhang, J | 1 |
Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO | 1 |
Dai, M; Kyei-Baffour, K; Mohammad, H; Seleem, MN | 1 |
Abuelkhir, AA; Abutaleb, NS; Attia, AS; Elsebaie, MM; Liang, HW; Mayhoub, AS; Nour El-Din, HT; Seleem, MN | 1 |
Akhir, A; Chopra, S; Kaul, G; Meenu, MT; Radhakrishnan, KV; Shukla, M | 1 |
Hamilton-Miller, JM | 1 |
Benn, R | 1 |
Besnier, JM; Choutet, P; Cotty, P; Fenneteau, A; Kanoun, F; Martin, C | 1 |
Felmingham, D; Hassan, H; O'Hare, MD | 1 |
Simon, M; Simon, VC | 1 |
Pohlod, DJ; Saravolatz, LD; Somerville, MM | 1 |
Barry, AL; Jones, RN; Thornsberry, C | 1 |
Durgham, SM; Ishag, AH; Shibl, AM | 1 |
Lindmark, A; Nord, CE; Persson, I | 1 |
Bauer, D; Spohr, M; Traub, WH | 1 |
Falkiner, FR; Jones, L; Keane, CT; Mooney, D; Moorhouse, EC; Mulvihill, TE | 1 |
Cohen, J; Ferreira, AC | 1 |
Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
Chandrasekar, PH; DeLorenzo, W; Levine, DP; Unowsky, J | 1 |
Barry, AL; Jones, RN | 1 |
Bourgault, AM; Bryan, L; Harding, GJ; Henry, DA; Hoban, DJ; Horsman, GB; Marrie, T; Smith, JA; Turgeon, P | 1 |
Breyer, S; Francesconi, M; Georgopoulos, A; Graninger, W; Leitha, T; Lenz, K | 1 |
Bartlett, JG | 1 |
Raz, R | 1 |
Jeljaszewicz, J; Lund, E; Pulverer, G | 1 |
Beck, D; Siegenthaler, G; Siegenthaler, W; Weidmann, P | 1 |
Pulverer, G | 1 |
Gombosuren, T; Jezek, Z; Mingir, G; Rusinko, M | 1 |
Fomina, IP; Kuznetsova, SM; Speranskaia, ON | 1 |
Lin'kov, GI; Vernikova, LM; Zhukovskaia, SA | 1 |
Vacek, V | 1 |
Gallien, R | 1 |
Chan, HC; Chan, TL; Feng, PH | 1 |
Olsen, H | 2 |
Browder, HP; Harrison, EF; Tavormina, PA; Zygmunt, WA | 1 |
Guenthner, SH; Wenzel, RP | 1 |
Archer, G; Bornholm, J; Yu, VL; Zuravleff, JJ | 1 |
Foldes, M; Munro, R; Shanker, S; Sorrell, TC; Toohey, M | 1 |
Harvey, K; Pavillard, R | 1 |
Douglas, DK; Westwood, G | 1 |
Pagan, FS | 1 |
Caillon, J; Drugeon, HB; Juvin, ME | 1 |
Cooper, B; Freeman, C; Mazens-Sullivan, M; Nightingale, C; Quintiliani, R; Robinson, A | 1 |
Carbon, C; Duval, J; Fantin, B; Leclercq, R | 1 |
Endtz, HP; Gyssens, IC; Löwenberg, B; Silbermann, MH; Wielenga, JJ | 1 |
Graninger, W; Hasenhündl, M; Hirschl, AM; Parschalk, B; Wenisch, C | 1 |
Pfeiffer, M; Scholl, E; Wachol-Drewek, Z | 1 |
Cuschieri, P; Galizia, AC; Vassallo, J | 1 |
Barbiery, P; Courcol, RJ; Roussel-Delvallez, M; Wallet, F | 1 |
Bryskier, A; Capper, T; Klugman, KP | 1 |
Andrieu, P; Archambaud, M; Brown, L; Cougot, P; Decun, JF; Georges, B; Mazerolles, M; Suc, C; Virenque, C | 1 |
Fallgren, C; Ljungh, A; Petersson, AC; Utt, M; Wadström, T | 1 |
Durandy, Y; Hulin, S | 1 |
Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
Brade, V; Hunfeld, KP; Kekoukh, E; Kraiczy, P; Weigand, J; Wichelhaus, TA | 1 |
Gottlieb, T; Leroi, MJ; Siarakas, S | 1 |
Siristonpun, Y; Tanphaichitra, D | 1 |
Bobin-Dubreux, S; Byl, B; Denis, O; Knoop, C; Nonhoff, C; Struelens, MJ | 1 |
Grohs, P; Gutmann, L; Kitzis, MD | 1 |
WILLIAMS, RE | 1 |
Cahill, RA; Kieran, SM; Sheehan, SJ | 1 |
Chen, YS; Chia, YY; Chiang, HL; Hung, CC; Liu, K; Lo, Y | 1 |
Aral, M; Atahan, E; Ciragil, P; Ergun, Y; Gul, M; Yasim, A | 1 |
Akerlund, T; Aspevall, O; Burman, LG; Lundberg, A; Svenungsson, B | 1 |
Al-Obaid, I; Al-Sweih, N; Dhar, R; Gomaa, HH; Johny, M; Mokaddas, E; Rotimi, VO; Udo, EE | 1 |
Odenholt, I; Walder, M; Wullt, M | 1 |
Nelson, R | 1 |
Li, R; Liu, C; Sun, XG; Wang, ZQ | 1 |
Bargiotas, KA; Dailiana, ZH; Gougoulias, NE; Malizos, KN; Paridis, D; Varitimidis, S | 1 |
Karageorgos, ACh; Lambiris, EE; Marangos, MN; Saridis, AG; Tyllianakis, ME | 1 |
Aral, M; Gul, M; Yasim, A | 1 |
Farrell, DJ; Love, WG; Rhys-Williams, W; Robbins, M | 1 |
Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
Johnson, S; Venugopal, AA | 1 |
Frimodt-Møller, N; Vingsbo Lundberg, C | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Argemi, X; Baldeyrou, M; Christmann, D; Cianférani, S; Douiri, N; Hansmann, Y; Keller, D; Lefebvre, N; Meghit, K; Meyer, N; Prévost, G; Riegel, P; Ronde Oustau, C; Strub, JM | 1 |
Bogdan, C; Kiefer, A; Melichar, VO | 1 |
Alfaresi, M; Celiloglu, H; Ehricht, R; Gawlik, D; Monecke, S; Müller, E; Nabi, A; Nassar, R; Reissig, A; Rizvi, I; Senok, A; Weber, S | 1 |
Fazeli, MR; Sepahi, AA; Shariatmadari, F; Zamani, N | 1 |
5 review(s) available for fusidic acid and vancomycin
Article | Year |
---|---|
Antimicrobial agents acting against anaerobes.
Topics: Aminoglycosides; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Clindamycin; Colistin; Disease Models, Animal; Erythromycin; Fusidic Acid; Humans; Lactams; Lincomycin; Microbial Sensitivity Tests; Nitrofurans; Nitroimidazoles; Polymyxins; Rifamycins; Sulfamethoxazole; Tetracyclines; Trimethoprim; Vancomycin | 1975 |
Characteristics of several smaller antibiotics.
Topics: Anti-Bacterial Agents; Fusidic Acid; Half-Life; Kinetics; Lincomycin; Novobiocin; Peptides; Ristocetin; Steroids; Vancomycin | 1971 |
Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains.
Topics: Australia; beta-Lactamases; Cephalosporins; Drug Therapy, Combination; Floxacillin; Fusidic Acid; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Teicoplanin; Treatment Outcome; Vancomycin | 2007 |
Current state of Clostridium difficile treatment options.
Topics: Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fusidic Acid; Humans; Metronidazole; Nitro Compounds; Secondary Prevention; Severity of Illness Index; Teicoplanin; Thiazoles; Treatment Outcome; Vancomycin | 2012 |
3 trial(s) available for fusidic acid and vancomycin
Article | Year |
---|---|
Treatment of Clostridium difficile colitis.
Topics: Animals; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Random Allocation; Vancomycin | 1985 |
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fusidic Acid; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Teicoplanin; Vancomycin | 1996 |
Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cefuroxime; Fusidic Acid; Hip Prosthesis; Humans; Incidence; Knee Prosthesis; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2010 |
90 other study(ies) available for fusidic acid and vancomycin
Article | Year |
---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Exotoxins; Leukocidins; Microbial Sensitivity Tests; Staphylococcus aureus | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine | 2009 |
In vitro bactericidal activity of iclaprim in human plasma.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Plasma; Pyrimidines; Staphylococcus aureus | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Cricetinae; Cricetulus; Drug Synergism; Fibroblasts; Gram-Negative Bacteria; Guinea Pigs; Lung; Male; Microbial Sensitivity Tests; Polymyxin B; Rats; Structure-Activity Relationship | 2010 |
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
Topics: Anti-Bacterial Agents; Indonesia; Methicillin; Methicillin Resistance; Phylogeny; Polymerase Chain Reaction; Staphylococcus | 2010 |
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Enzyme Assays; Escherichia coli; Gene Expression; Kinetics; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Phthalic Anhydrides; Spermidine; Succinic Anhydrides | 2015 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mice; Microsomes, Liver; Staphylococcal Infections; Thiazoles | 2018 |
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Methicillin; Mice; Microbial Sensitivity Tests; Molecular Structure; Skin Diseases, Bacterial; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin; Wound Infection | 2018 |
Second-generation aryl isonitrile compounds targeting multidrug-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Disease Models, Animal; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nitriles; Skin Diseases; Staphylococcal Infections | 2019 |
Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Methicillin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin; Vancomycin-Resistant Staphylococcus aureus | 2022 |
Developing the Natural Prenylflavone Artocarpin from
Topics: Animals; Anti-Bacterial Agents; Artocarpus; Biofilms; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Treatment of bacterial endocarditis 1976.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Hypersensitivity; Endocarditis, Bacterial; Enterococcus faecalis; Fusidic Acid; Humans; Lincomycin; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Streptococcus sanguis; Vancomycin | 1976 |
Failure of a combination of vancomycin and fusidic acid in a patient with staphylococcal infection.
Topics: Aged; Drug Combinations; Female; Fusidic Acid; Humans; Staphylococcal Infections; Vancomycin | 1991 |
In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Clindamycin; Depsipeptides; Drug Resistance, Microbial; Fusidic Acid; Glycopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Teicoplanin; Vancomycin | 1990 |
Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Topics: Catheters, Indwelling; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Glycopeptides; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1990 |
In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
Topics: Anti-Bacterial Agents; Daptomycin; Fusidic Acid; Glycopeptides; Gram-Positive Bacteria; Microbial Sensitivity Tests; Peptides; Rifampin; Teicoplanin; Vancomycin | 1987 |
Evaluation of teicoplanin and vancomycin disk susceptibility tests.
Topics: Aminocoumarins; Anti-Bacterial Agents; Bacteria; Corynebacterium; Coumarins; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Enterobacteriaceae; Fusidic Acid; Glycopeptides; Microbial Sensitivity Tests; Pseudomonas; Streptococcus; Teicoplanin; Vancomycin | 1986 |
Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Topics: Fusidic Acid; Gentamicins; Glycopeptides; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1988 |
Susceptibility of Clostridium difficile to LY146032.
Topics: Anti-Bacterial Agents; Bacitracin; Clostridium; Daptomycin; Fusidic Acid; Humans; Metronidazole; Microbial Sensitivity Tests; Peptides; Vancomycin | 1987 |
Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
Topics: Animals; Anti-Bacterial Agents; Blood; Cattle; Enterococcus faecalis; Fibrin; Fusidic Acid; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Penicillins; Rabbits; Thienamycins; Vancomycin | 1986 |
The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fusidic Acid; Gentamicins; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Quinolines; Rifampin; Staphylococcus aureus; Staphylococcus Phages; Teicoplanin; Vancomycin | 1985 |
Staphylococcus epidermidis endocarditis and mitral valve prolapse.
Topics: Adult; Endocarditis, Bacterial; Floxacillin; Fusidic Acid; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Prolapse; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1988 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Drug Combinations; Female; Fusidic Acid; Methicillin; Mice; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
In vitro activity of ciprofloxacin against gram-positive cocci.
Topics: Ciprofloxacin; Drug Evaluation, Preclinical; Enterobacteriaceae; Fusidic Acid; Gram-Positive Bacteria; Microbial Sensitivity Tests; Staphylococcus; Streptococcus; Vancomycin | 1987 |
Comparison of agar disk diffusion, microdilution broth, and agar dilution for testing antimicrobial susceptibility of coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Cephalosporins; Coagulase; Culture Media; Drug Resistance, Microbial; Fusidic Acid; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rifampin; Sodium Chloride; Staphylococcus; Temperature; Vancomycin | 1987 |
Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Topics: Cefamandole; Clindamycin; Fosfomycin; Fusidic Acid; Gentamicins; Imipenem; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1985 |
[Vancomycin, erythromycin and fusidic acid].
Topics: Bacterial Infections; Erythromycin; Fusidic Acid; Humans; Vancomycin | 1985 |
Serological types of Diplococcus pneumoniae strains isolated in Germany. Comparison with type patterns in other countries.
Topics: Cephaloridine; Chloramphenicol; Drug Combinations; Erythromycin; Fusidic Acid; Germany, West; Humans; Lincomycin; Microbial Sensitivity Tests; Nitrofurans; Novobiocin; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Serotyping; Sputum; Streptococcus pneumoniae; Sulfamethoxazole; Sulfonamides; Tetracycline; Trimethoprim; Vancomycin | 1974 |
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol].
Topics: Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Neomycin; Novobiocin; Oleandomycin; Paromomycin; Polymyxins; Rifampin; Ristocetin; Spectinomycin; Vancomycin; Virginiamycin | 1968 |
[Actual medical importance and antibiotic resistance of staphylococci].
Topics: Ampicillin; Cephaloridine; Chloramphenicol; Erythromycin; Fusidic Acid; Gentamicins; Germany, West; Lincomycin; Novobiocin; Oxacillin; Penicillin G; Penicillin Resistance; Staphylococcus; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 1972 |
Antibiotic sensitivity of staphylococci isolated in Ulanbator. On the occasion of the 50th anniversary of the Mongolian health services.
Topics: Anti-Bacterial Agents; Cephaloridine; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Kanamycin; Leucomycins; Lincomycin; Microbial Sensitivity Tests; Mongolia; Neomycin; Oxacillin; Penicillin Resistance; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1972 |
[Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Chloramphenicol; Dicloxacillin; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Methicillin; Oxacillin; Penicillin G; Penicillin Resistance; Penicillinase; Rifampin; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1973 |
[Recovery of antibiotics from mycelial deposits].
Topics: Anti-Bacterial Agents; Cycloserine; Fusidic Acid; Novobiocin; Oleandomycin; Oxytetracycline; Penicillins; Streptomycin; Tetracycline; Vancomycin | 1973 |
Clinical value of antistaphylococcal drugs.
Topics: Acute Disease; Anti-Infective Agents; Cephalosporins; Chronic Disease; Czechoslovakia; Drug Evaluation; Endocarditis, Bacterial; Erythromycin; Fusidic Acid; Gentamicins; Humans; Lincomycin; Novobiocin; Osteomyelitis; Penicillins; Recurrence; Rifamycins; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Vancomycin | 1973 |
Penicillin resistant staphylococcal septicaemia successfully treated with vancomycin and fucidin.
Topics: Adult; Female; Fusidic Acid; Humans; Penicillin Resistance; Sepsis; Staphylococcal Infections; Vancomycin | 1972 |
An in vitro study of the antibiotic sensitivity of Flavobacterium meningosepticum.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Erythromycin; Flavobacterium; Fusidic Acid; Humans; In Vitro Techniques; Infant, Newborn; Infant, Premature, Diseases; Meningitis; Novobiocin; Penicillin G; Penicillin Resistance; Rolitetracycline; Streptomycin; Sulfonamides; Vancomycin | 1967 |
Comparative inhibition of methicillin-resistant strains of Staphylococcus aureus by lysostaphin and other antibiotics.
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Lincomycin; Lysostaphin; Methicillin; Novobiocin; Penicillin Resistance; Penicillins; Staphylococcus; Tetracycline; Vancomycin | 1968 |
The sensitivity of Flavobacterium meningosepticum to antibiotics at different temperatures. An in vitro study.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Erythromycin; Flavobacterium; Fusidic Acid; Humans; Infant, Newborn; Infant, Premature, Diseases; Meningitis; Novobiocin; Penicillins; Streptomycin; Sulfonamides; Temperature; Tetracycline; Vancomycin | 1967 |
Novobiocin, fucidin, and vancomycin.
Topics: Drug Resistance, Microbial; Endocarditis, Bacterial; Fusidic Acid; Humans; Novobiocin; Staphylococcal Infections; Vancomycin | 1968 |
In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Floxacillin; Fosfomycin; Fusidic Acid; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Vancomycin | 1984 |
In-vitro synergy testing of triple antibiotic combinations against Staphylococcus epidermidis isolates from patients with endocarditis.
Topics: Anti-Bacterial Agents; Dicloxacillin; Drug Combinations; Drug Synergism; Endocarditis, Bacterial; Fusidic Acid; Gentamicins; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Vancomycin | 1984 |
In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Topics: Culture Media; Fusidic Acid; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcus aureus; Vancomycin | 1983 |
Administrative considerations in an infective outbreak.
Topics: Australia; Costs and Cost Analysis; Cross Infection; Disease Outbreaks; Fusidic Acid; Hospital Administration; Humans; Methicillin; Patient Care Planning; Patient Isolation; Penicillin Resistance; Personnel, Hospital; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Antibiotics for gram-positive organisms.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Cloxacillin; Erythromycin; Fusidic Acid; Humans; Lincomycin; Penicillins; Vancomycin | 1981 |
In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 1994 |
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Novobiocin; Peptides, Cyclic; Quinolones; Teicoplanin; Vancomycin; Virginiamycin | 1995 |
Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Topics: Animals; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Fusidic Acid; Humans; Methicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1993 |
[A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin].
Topics: Adolescent; Anti-Bacterial Agents; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Humans; Male; Meningitis, Bacterial; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1995 |
Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin.
Topics: Anti-Bacterial Agents; Cefotaxime; Clindamycin; Collagen; Drug Delivery Systems; Fusidic Acid; Gentamicins; Microscopy, Electron, Scanning; Prostheses and Implants; Surgical Sponges; Vancomycin; Wound Infection | 1996 |
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination; Fluconazole; Fusidic Acid; Humans; Imipenem; Immunocompromised Host; Male; Methicillin Resistance; Nocardia Infections; Pneumonia; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 1996 |
Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.
Topics: Amikacin; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fusidic Acid; Logistic Models; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Vancomycin | 1997 |
In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fusidic Acid; Levofloxacin; Mutation; Ofloxacin; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1996 |
[Severe methicillin-resistant Staphylococcus aureus infections. Emergence of resistance to fusidic acid or fosfomycin during treatment with continuous infusion of vancomycin].
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fosfomycin; Fusidic Acid; Humans; Infusions, Intravenous; Male; Methicillin Resistance; Middle Aged; Retrospective Studies; Staphylococcal Infections; Time Factors; Vancomycin | 1997 |
In vitro anti-staphylococcal activity of heparinized biomaterials bonded with combinations of rifampicin.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Cefuroxime; Collagen; Fusidic Acid; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1998 |
[Postoperative mediastinitis due to methicillin resistant Staphylococcus epidermidis with low sensitivity to vancomycin].
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fusidic Acid; Humans; Infant, Newborn; Male; Mediastinitis; Methicillin Resistance; Microbial Sensitivity Tests; Postoperative Complications; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Vancomycin | 1997 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi.
Topics: Anti-Bacterial Agents; Aztreonam; Borrelia burgdorferi Group; Drug Resistance, Microbial; Fusidic Acid; Humans; Meropenem; Mezlocillin; Microbial Sensitivity Tests; Monobactams; Penicillins; Ribostamycin; Teicoplanin; Thienamycins; Vancomycin | 2001 |
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin | 2002 |
Value of Clostridium difficile antigen test in immunocompromised hosts in the tropics.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Immunocompromised Host; Tropical Climate; Vancomycin | 1991 |
Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features.
Topics: Adolescent; Belgium; Cross Infection; Drug Therapy, Combination; Female; Fusidic Acid; Genotype; Hospitals, University; Humans; Infusions, Intravenous; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2002 |
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Fusidic Acid; Gentamicins; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus aureus; Vancomycin | 2003 |
L FORMS OF STAPHYLOCOCCUS AUREUS.
Topics: Anti-Bacterial Agents; Bacitracin; Chloramphenicol; Colistin; Culture Media; Cycloserine; Drug Resistance, Microbial; Erythromycin; Fusidic Acid; Kanamycin; L Forms; Methicillin; Neomycin; Novobiocin; Penicillin G; Penicillin Resistance; Research; Ristocetin; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus Phages; Streptomycin; Sulfonamides; Tetracycline; Vancomycin | 1963 |
Mycotic peripheral aneurysms and intracerebral abscesses secondary to infective endocarditis.
Topics: Aneurysm, Infected; Anti-Bacterial Agents; Brain Abscess; Catheterization, Peripheral; Catheters, Indwelling; Cellulitis; Chloramphenicol; Dehydration; Endocarditis, Bacterial; Fluid Therapy; Forearm; Fusidic Acid; Humans; Leg; Male; Middle Aged; Staphylococcal Infections; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Vancomycin | 2004 |
Epidural abscess in an obstetric patient with patient-controlled epidural analgesia--a case report.
Topics: Adult; Analgesia, Patient-Controlled; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthetics, Local; Anti-Bacterial Agents; Epidural Abscess; Epinephrine; Female; Fusidic Acid; Humans; Lidocaine; Magnetic Resonance Imaging; Osteomyelitis; Pregnancy; Vancomycin; Vasoconstrictor Agents | 2005 |
Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Blood Vessel Prosthesis; Female; Fusidic Acid; Infusions, Parenteral; Prosthesis-Related Infections; Random Allocation; Rats; Rats, Sprague-Dawley; Teicoplanin; Vancomycin | 2006 |
Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Drug Resistance, Bacterial; Fusidic Acid; Hospitals, University; Humans; Metronidazole; Microbial Sensitivity Tests; Ribotyping; Serotyping; Sweden; Vancomycin | 2006 |
Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004.
Topics: Acetates; Benzamidines; Cadmium; Drug Resistance, Bacterial; Ethidium; Fusidic Acid; Gentamicins; Humans; Methicillin Resistance; Plasmids; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2006 |
Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Dose-Response Relationship, Drug; Fusidic Acid; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2007 |
[Analysis on the susceptibility of fusidic acid for common gram positive bacteria].
Topics: Anti-Bacterial Agents; Fusidic Acid; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus; Tobramycin; Vancomycin | 2009 |
Ankle and foot osteomyelitis: treatment protocol and clinical results.
Topics: Adolescent; Adult; Aged; Ankle Injuries; Anti-Bacterial Agents; Bacterial Infections; Chronic Disease; Clinical Protocols; Diabetic Foot; Drug Combinations; Female; Foot Injuries; Fractures, Bone; Fusidic Acid; Humans; Male; Middle Aged; Orthopedic Procedures; Osteomyelitis; Plastic Surgery Procedures; Polymethyl Methacrylate; Recovery of Function; Reoperation; Soft Tissue Injuries; Treatment Outcome; Vancomycin; Young Adult | 2010 |
The levels of cytokines in rats following the use of prophylactic agents in vascular graft infection.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Blood Vessel Prosthesis; Cytokines; Female; Fusidic Acid; Methicillin-Resistant Staphylococcus aureus; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Teicoplanin; Vancomycin | 2010 |
Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Daptomycin; Diterpenes; Fusidic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Mupirocin; Polymerase Chain Reaction; Porphyrins; Sequence Analysis, DNA; Vancomycin | 2011 |
[Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Cefoxitin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Moscow; Oxacillin; Oxazolidinones; Rifampin; Surgery, Plastic; Vancomycin | 2011 |
Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Female; Fusidic Acid; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Staphylococcal Skin Infections; Vancomycin; Wound Infection | 2013 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Aminoglycosides; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fluoroquinolones; Follow-Up Studies; Fosfomycin; Fusidic Acid; Humans; Male; Metalloproteases; Methicillin; Middle Aged; Phosphonoacetic Acid; Prospective Studies; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus lugdunensis; Vancomycin; Virulence Factors | 2017 |
Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
Topics: Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Baths; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Fusidic Acid; Hand Disinfection; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Retrospective Studies; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Genotyping of methicillin resistant Staphylococcus aureus from the United Arab Emirates.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Fusidic Acid; Genotype; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; New York; Sri Lanka; Staphylococcal Infections; United Arab Emirates; Vancomycin; Virulence Factors | 2020 |
A new probiotic Lactobacillus plantarum strain isolated from traditional dairy together with nanochitosan particles shows the synergistic effect on aflatoxin B1 detoxification.
Topics: Aflatoxin B1; Anti-Bacterial Agents; Chitosan; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Lactobacillales; Lactobacillus plantarum; Nalidixic Acid; Neomycin; Ofloxacin; Probiotics; Vancomycin | 2022 |